Cidara Therapeutics Inc (CDTX)
13.43
+0.40
(+3.07%)
USD |
NASDAQ |
Nov 05, 16:00
13.43
0.00 (0.00%)
After-Hours: 18:11
Cidara Therapeutics Price to Book Value: 0.7219 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 0.7004 |
| November 01, 2024 | 0.7036 |
| October 31, 2024 | 0.6988 |
| October 30, 2024 | 0.6897 |
| October 29, 2024 | 0.7198 |
| October 28, 2024 | 0.6703 |
| October 25, 2024 | 0.6773 |
| October 24, 2024 | 0.5999 |
| October 23, 2024 | 0.6074 |
| October 22, 2024 | 0.6117 |
| October 21, 2024 | 0.6031 |
| October 18, 2024 | 0.6053 |
| October 17, 2024 | 0.5993 |
| October 16, 2024 | 0.5773 |
| October 15, 2024 | 0.5467 |
| October 14, 2024 | 0.5537 |
| October 11, 2024 | 0.5703 |
| October 10, 2024 | 0.5655 |
| October 09, 2024 | 0.5832 |
| October 08, 2024 | 0.5757 |
| October 07, 2024 | 0.5983 |
| October 04, 2024 | 0.5859 |
| October 03, 2024 | 0.5752 |
| October 02, 2024 | 0.5671 |
| October 01, 2024 | 0.5703 |
| Date | Value |
|---|---|
| September 30, 2024 | 0.5778 |
| September 27, 2024 | 0.5773 |
| September 26, 2024 | 0.58 |
| September 25, 2024 | 0.5816 |
| September 24, 2024 | 0.5789 |
| September 23, 2024 | 0.5843 |
| September 20, 2024 | 0.6058 |
| September 19, 2024 | 0.63 |
| September 18, 2024 | 0.6246 |
| September 17, 2024 | 0.6251 |
| September 16, 2024 | 0.6343 |
| September 13, 2024 | 0.6418 |
| September 12, 2024 | 0.6101 |
| September 11, 2024 | 0.6246 |
| September 10, 2024 | 0.6423 |
| September 09, 2024 | 0.6289 |
| September 06, 2024 | 0.6149 |
| September 05, 2024 | 0.6208 |
| September 04, 2024 | 0.6082 |
| September 03, 2024 | 0.623 |
| August 30, 2024 | 0.6391 |
| August 29, 2024 | 0.6961 |
| August 28, 2024 | 0.6966 |
| August 27, 2024 | 0.6972 |
| August 26, 2024 | 0.6915 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3929
Minimum
Jul 11 2024
68.91
Maximum
Apr 01 2021
7.995
Average
4.177
Median
Price to Book Value Benchmarks
| Biomarin Pharmaceutical Inc | 2.326 |
| Arbutus Biopharma Corp | 6.097 |
| GlycoMimetics Inc | 1.253 |
| FibroGen Inc | -- |
| Cue Biopharma Inc | 4.748 |
Price to Book Value Related Metrics
| PS Ratio | 1.559 |
| PEG Ratio | -0.0006 |
| Price | 13.43 |
| Earnings Yield | -188.2% |
| Market Cap | 94.52M |
| PEGY Ratio | -0.0006 |